End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
59,800 KRW | -0.17% | +1.70% | -16.94% |
05-03 | SK Bioscience's Attributable Loss Narrows in Q1 | MT |
03-28 | SK Bioscience Signs Deal with Sanofi for Five Vaccine Types | MT |
ETFs positioned on SK bioscience Co.,Ltd.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.57% | 2 M€ | -14.14% | ||
0.78% | 14 M€ | -4.28% | ||
0.04% | 15 M€ | +15.41% | ||
0.02% | 2,867 M€ | +9.57% | - | |
0.02% | 454 M€ | +8.01% | - | |
0.02% | 153 M€ | +5.91% | - | |
0.02% | 4 M€ | -4.41% | - | |
0.01% | 112 M€ | +4.31% | - | |
0.01% | 7 M€ | +4.81% | - | |
0.00% | 45 M€ | 0.00% | - | |
0.00% | 34 M€ | +8.24% | - | |
0.00% | 306 M€ | +5.68% | - | |
0.00% | 39 M€ | +5.63% | - | |
0.00% | 34 M€ | +3.77% | - | |
0.00% | 7 M€ | +0.11% | - |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-16.94% | 3.36B | |
-2.35% | 89.08B | |
+2.76% | 40.9B | |
-13.39% | 32.25B | |
+54.69% | 25.14B | |
-16.17% | 15.39B | |
-8.84% | 11.91B | |
-42.60% | 11.89B | |
-12.82% | 11.64B | |
+7.34% | 9.03B |
- Stock Market
- Equities
- A302440 Stock
- Funds and ETFs SK bioscience Co.,Ltd.